Skip to content
10-Q

Quarterly Report

Hoth Therapeutics, Inc. RKTO

0001213900-26-057726

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 14, 2026 19.13M sh
Shares Diluted Q1 2026 · Mar 31, 2026 15.79M sh
Shares Diluted Q1 2026 · Mar 31, 2025 12.73M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$3.05M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$2.79M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $4.05M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $6.25M
Stockholders Equity Q1 2026 · Mar 31, 2026 $4.16M
Stockholders Equity Q1 2026 · Dec 31, 2025 $6.15M
Stockholders Equity Q1 2026 · Mar 31, 2025 $11.54M
Stockholders Equity Q1 2026 · Dec 31, 2024 $6.88M
Current Liabilities Q1 2026 · Mar 31, 2026 $1.43M
Current Liabilities Q1 2026 · Dec 31, 2025 $1.45M
Total Liabilities Q1 2026 · Mar 31, 2026 $1.43M
Total Liabilities Q1 2026 · Dec 31, 2025 $1.45M
Current Assets Q1 2026 · Mar 31, 2026 $4.86M
Current Assets Q1 2026 · Dec 31, 2025 $6.86M
Total Assets Q1 2026 · Mar 31, 2026 $5.59M
Total Assets Q1 2026 · Dec 31, 2025 $7.6M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.17
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.27
Eps Basic Q1 2026 · Mar 31, 2026 −$0.17
Eps Basic Q1 2026 · Mar 31, 2025 −$0.27
Rd Expense Q1 2026 · Mar 31, 2026 $1.52M
Rd Expense Q1 2026 · Mar 31, 2025 $1.96M
Net Income Q1 2026 · Mar 31, 2026 −$2.69M
Net Income Q1 2026 · Mar 31, 2025 −$3.48M
Operating Income Q1 2026 · Mar 31, 2026 −$2.65M
Operating Income Q1 2026 · Mar 31, 2025 −$3.48M